Standout Papers

Regorafenib plus best supportive care versus placebo plus best supportive care in Asian patients wit... 2015 2026 2018 2022 536
  1. Regorafenib plus best supportive care versus placebo plus best supportive care in Asian patients with previously treated metastatic colorectal cancer (CONCUR): a randomised, double-blind, placebo-controlled, phase 3 trial (2015)
    Jin Li, Shukui Qin et al. The Lancet Oncology

Immediate Impact

68 standout
Sub-graph 1 of 22

Citing Papers

Spatial determinants of antibody-drug conjugate SHR-A1811 efficacy in neoadjuvant treatment for HER2-positive breast cancer
2025 Standout
ROS: Executioner of regulating cell death in spinal cord injury
2024 Standout
1 intermediate paper

Works of Dong Ma being referenced

Melatonin Attenuates Spinal Cord Injury in Mice by Activating the Nrf2/ARE Signaling Pathway to Inhibit the NLRP3 Inflammasome
2022
Regorafenib plus best supportive care versus placebo plus best supportive care in Asian patients with previously treated metastatic colorectal cancer (CONCUR): a randomised, double-blind, placebo-controlled, phase 3 trial
2015 Standout

Author Peers

Author Last Decade Papers Cites
Dong Ma 682 352 160 186 36 927
Federico Nasroulah 809 389 202 189 28 969
Regina Esser 899 463 111 195 39 1.1k
Roberto Carmagnani Pestana 526 262 210 196 50 1.0k
J. Kalmus 692 288 116 185 22 995
Diana L. Hanna 580 244 231 117 74 973
Alessia Mennitto 526 449 259 48 58 960
Julian Walter Holch 795 339 129 200 48 1.1k
Lin Shen 558 430 147 46 29 794
E. Dawn Flick 398 331 216 69 43 835
André T. Brunetto 438 255 510 116 56 1.2k

All Works

Loading papers...

Rankless by CCL
2026